Want to see IN:MUKKA full AI Analyst Report?
MUKKA Stock Chart & Stats
₹23.74
₹0.02(0.05%)
At close: 4:00 PM EST
₹23.74
₹0.02(0.05%)
Day’s Range― - ―
52-Week Range₹18.32 - ₹31.20
Previous CloseN/A
Volume628.76K
Average Volume (3M)40.24K
Market Cap
₹7.19B
Enterprise Value₹14.66B
Total Cash (Recent Filing)₹30.75M
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)13.8
Beta0.80
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.45
Shares Outstanding300,000,000
10 Day Avg. Volume18,929
30 Day Avg. Volume40,240
Financial Highlights & Ratios
PEG Ratio0.87
Price to Book (P/B)1.11
Price to Sales (P/S)0.38
P/FCF Ratio-1.86
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Revenue GrowthSustained multi-year top-line expansion and a ~45% rebound in 2026 indicate durable demand and successful market penetration. Strong revenue growth supports scale economics, improves bargaining power with suppliers and customers, and underpins longer-term strategic investments.
Consistent Reported ProfitabilityConsistent reported profits across the period show the business can generate accounting earnings despite volatility in raw-materials and prices. This persistence implies pricing ability or cost control that can sustain operations and fund incremental working capital when needed.
Niche Marine Ingredient SupplierFocused exposure to fish meal and fish oil for aquafeed and animal feed provides structural demand driven by global aquaculture and animal-protein growth. Export orientation diversifies market access and ties the business to long-term nutrition and feed trends.
Bears Say
Negative Operating & Free Cash FlowPersistently negative operating and free cash flows show the business is not self-funding growth, forcing reliance on external financing. This reduces financial resilience, raises refinancing risk, and can constrain capital allocation for maintenance, expansion or margin improvement initiatives.
Rising LeverageA sharp increase in debt in 2026 materially raises leverage and interest obligations, weakening balance-sheet flexibility. Higher indebtedness heightens sensitivity to cash-flow volatility and could force costlier refinancing or equity raises, impairing long-term strategic optionality.
Thin & Pressured MarginsLow net margins limit the company's buffer against input-cost swings common in commodity-based marine ingredients. Margin pressure when revenue rises suggests reduced pricing power or rising costs, constraining reinvestment, return on capital, and long-term profitability resilience.
Mukka Proteins Limited News
MUKKA FAQ
What was Mukka Proteins Limited’s price range in the past 12 months?
Mukka Proteins Limited lowest stock price was ₹18.32 and its highest was ₹31.20 in the past 12 months.
What is Mukka Proteins Limited’s market cap?
Mukka Proteins Limited’s market cap is ₹7.19B.
When is Mukka Proteins Limited’s upcoming earnings report date?
Mukka Proteins Limited’s upcoming earnings report date is Aug 19, 2026 which is in 45 days.
How were Mukka Proteins Limited’s earnings last quarter?
Mukka Proteins Limited released its earnings results on May 15, 2026. The company reported ₹0.69 earnings per share for the quarter, beating the consensus estimate of N/A by ₹0.69.
Is Mukka Proteins Limited overvalued?
According to Wall Street analysts Mukka Proteins Limited’s price is currently Overvalued.
Does Mukka Proteins Limited pay dividends?
Mukka Proteins Limited does not currently pay dividends.
What is Mukka Proteins Limited’s EPS estimate?
Mukka Proteins Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Mukka Proteins Limited have?
Mukka Proteins Limited has 300,000,000 shares outstanding.
What happened to Mukka Proteins Limited’s price movement after its last earnings report?
Mukka Proteins Limited reported an EPS of ₹0.69 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.461%.
Which hedge fund is a major shareholder of Mukka Proteins Limited?
Currently, no hedge funds are holding shares in IN:MUKKA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Mukka Proteins Limited
Mukka Proteins Limited, based in Mangaluru, India, operates as a prominent manufacturer and supplier of protein products, extending its reach both domestically and internationally. The company specializes in a variety of fish-derived offerings, including fish meal, fish oil, and soluble fish paste. Expanding its portfolio, it also produces insect meal and insect oil. These versatile ingredients serve a wide range of industrial applications, notably in enhancing animal, poultry, and aquaculture feeds, and are furthermore utilized in pharmaceutical goods, soap production, leather tanneries, and paint manufacturing. The firm maintains a robust global presence, exporting its products to numerous countries across Asia and beyond, such as Bahrain, China, South Korea, and Vietnam, among others. Established in 1960, the company officially rebranded in August 2021, transitioning from its former identity, Mukka Sea Food Industries Limited, to its current name, Mukka Proteins Limited.
Technical Analysis
Avanti Feeds Limited
―
Hatsun Agro Product Limited
―
M K Proteins Limited
―
Parag Milk Foods Ltd.
―
SKM Egg Products Export (India) Ltd.
―